It is a must to produce COVID-19 vaccines, treatment drugs at home: PM

by VNA28 November 2021 Last updated at 10:00 AM

Prime Minister Pham Minh Chinh speaks at the meeting. (Photo: VNA)
Prime Minister Pham Minh Chinh speaks at the meeting. (Photo: VNA)

It is a must to produce COVID-19 vaccines and treatment drugs domestically, Prime Minister Pham Minh Chinh said at a meeting with representatives from ministries and agencies in Hanoi on November 27.

He regarded the “5K principle”, vaccines, treatment drugs, technologies, public awareness and other solutions as crucial factors to safely and flexibly adapt to and effectively control the pandemic. The “ 5K principle ” was issued by the Ministry of Health, covering khau trang (facemask), khu khuan (disinfection), khoang cach (distance), khong tu tap (no gathering), and khai bao y te (health declaration).

PM Chinh applauded the Ministry of Health and relevant ministries and agencies, especially scientists, researchers and producers of COVID-19 vaccines and treatment drugs for their efforts over the past time. He called for closer coordination to remove difficulties in research as well as administrative and legal procedures, striving to produce COVID-19 vaccines and treatment drugs at home.

The nation’s interests, and the public’s health and life must be the top priority, the PM emphasised. PM Chinh assigned the Ministry of Health to coordinate with other relevant ministries and agencies to review institutions to facilitate the process.

The Ministry of Health reported that as of November 25, Vietnam had administered about 116.4 million doses of COVID-19 vaccines, with 47.4 million people fully vaccinated. The country has engaged in technology transfer, research and trial of such vaccines as Nano Covax, COVIVAC, ARCT-154, HIPRA, Sputnik V, Shionogi and some vaccines of Cuba and India. Six factories have registered for COVID-19 treatment drug production.

Tags:

Top VND Exchange Rates

Auto-refesh 15m

USD

EUR

AUD
1 VND
Inverse:
0.00004
22,510.0
0.00004
25,226.0
0.00006
15,674.0

Mid-market rates: 2024-11-24 01:22 UTC